Literature DB >> 17904601

New and evolving concepts in the neurotoxicology of lead.

L D White1, D A Cory-Slechta, M E Gilbert, E Tiffany-Castiglioni, N H Zawia, M Virgolini, A Rossi-George, S M Lasley, Y C Qian, Md Riyaz Basha.   

Abstract

Lead (Pb) is a xenobiotic metal with no known essential function in cellular growth, proliferation, or signaling. Decades of research characterizing the toxicology of Pb have shown it to be a potent neurotoxicant, especially during nervous system development. New concepts in the neurotoxicology of Pb include advances in understanding the mechanisms and cellular specificity of Pb. Experimental studies have shown that stress can significantly alter the effects of Pb, effects that could potentially be mediated through alterations in the interactions of glucocorticoids with the mesocorticolimbic dopamine system of the brain. Elevated stress, with corresponding elevated glucocorticoid levels, has been postulated to contribute to the increased levels of many diseases and dysfunctions in low socioeconomic status populations. Cellular models of learning and memory have been utilized to investigate the potential mechanisms of Pb-induced cognitive deficits. Examination of long-term potentiation in the rodent hippocampus has revealed Pb-induced increases in threshold, decreases in magnitude, and shorter retention times of synaptic plasticity. Structural plasticity in the form of adult neurogenesis in the hippocampus is also impacted by Pb exposure. The action of Pb on glutamate release, NMDA receptor function, or structural plasticity may underlie perturbations in synaptic plasticity and contribute to learning impairments. In addition to providing insight into potential mechanisms of Pb-induced cognitive deficits, cellular models offer an opportunity to investigate direct effects of Pb on isolated biological substrates. A target of interest is the 78-kDa molecular chaperone glucose-regulated protein (GRP78). GRP78 chaperones the secretion of the cytokine interleukin-6 (IL-6) by astrocytes. In vitro evidence shows that Pb strongly binds to GRP78, induces GRP78 aggregation, and blocks IL-6 secretion in astroglial cells. These findings provide evidence for a significant chaperone deficiency in Pb-exposed astrocytes in culture. In the long term, chaperone deficiency could underlie protein conformational diseases such as Alzheimer's Disease (AD). Lead exposure in early life has been implicated in subsequent progression of amyloidogenesis in rodents during old age. This exposure resulted in an increase in proteins associated with AD pathology viz., beta-amyloid precursor protein (beta-APP), and beta-amyloid (Abeta). These four new lines of research comprise compelling evidence that exposures to Pb have adverse effects on the nervous system, that environmental factors increase nervous system susceptibility to Pb, and that exposures in early life may cause neurodegeneration in later life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904601     DOI: 10.1016/j.taap.2007.08.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  111 in total

1.  Effects of developmental lead exposure on the hippocampal transcriptome: influences of sex, developmental period, and lead exposure level.

Authors:  Jay S Schneider; David W Anderson; Keyur Talsania; William Mettil; Rajanikanth Vadigepalli
Journal:  Toxicol Sci       Date:  2012-05-28       Impact factor: 4.849

2.  Mechanisms of lead and manganese neurotoxicity.

Authors:  April P Neal; Tomas R Guilarte
Journal:  Toxicol Res (Camb)       Date:  2013-03-01       Impact factor: 3.524

3.  Variations at a quantitative trait locus (QTL) affect development of behavior in lead-exposed Drosophila melanogaster.

Authors:  Helmut V B Hirsch; Debra Possidente; Sarah Averill; Tamira Palmetto Despain; Joel Buytkins; Valerie Thomas; W Paul Goebel; Asante Shipp-Hilts; Diane Wilson; Kurt Hollocher; Bernard Possidente; Greg Lnenicka; Douglas M Ruden
Journal:  Neurotoxicology       Date:  2009-01-21       Impact factor: 4.294

Review 4.  Molecular neurobiology of lead (Pb(2+)): effects on synaptic function.

Authors:  April P Neal; Tomás R Guilarte
Journal:  Mol Neurobiol       Date:  2010-11-02       Impact factor: 5.590

5.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

6.  Blood lead level association with lower body weight in NHANES 1999-2006.

Authors:  Franco Scinicariello; Melanie C Buser; Meike Mevissen; Christopher J Portier
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-04       Impact factor: 4.219

7.  No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication.

Authors:  Xiao-Min Li; Bing-Gen Zhu; Jian-Bo Ni; Chun-Yan Cao; Jie-Ping Zhang; Xu-Dong Zhao; Rong-Shen Zhu
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

8.  Influence of developmental lead exposure on expression of DNA methyltransferases and methyl cytosine-binding proteins in hippocampus.

Authors:  J S Schneider; S K Kidd; D W Anderson
Journal:  Toxicol Lett       Date:  2012-12-15       Impact factor: 4.372

Review 9.  Epigenetics of early-life lead exposure and effects on brain development.

Authors:  Marie-Claude Senut; Pablo Cingolani; Arko Sen; Adele Kruger; Asra Shaik; Helmut Hirsch; Steven T Suhr; Douglas Ruden
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

10.  Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Authors:  Lina Adwan; Gehad M Subaiea; Nasser H Zawia
Journal:  Neuropharmacology       Date:  2014-01-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.